Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?-Reference-Cited by-同舟云学术

Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?

Published:2017-06-21 Issue:7 Volume:6 Page:1581-1586
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Bender Carolin¹^ORCID,Enk Alexander¹,Gutzmer Ralf²,Hassel Jessica C.¹

Affiliation:

1. Department of Dermatology and National Center for Tumor Diseases; University Hospital Heidelberg; Im Neuenheimer Feld 440/460 Heidelberg 69120 Germany

2. Department of Dermatology and Allergy; Skin Cancer Center Hannover; Hannover Medical School; Ricklinger Str. 5 Hannover 30449 Germany

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.887/fullpdf

Reference15 articles.

1. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives;Buder;Cancer Med.,2013

2. Uveal melanoma;Spagnolo;Cancer Treat. Rev.,2012

3. Ipilimumab activity in advanced uveal melanoma;Khattak;Melanoma Res.,2013

4. Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma;Maio;Ann. Oncol.,2013

5. Phase II DeCOG-study of ipilimumab in pretreated and treatment-naive patients with metastatic uveal melanoma;Zimmer;PLoS ONE,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis;Scientific Reports;2024-04-03

2. New immunotherapy approaches as the most effective treatment for uveal melanoma;Critical Reviews in Oncology/Hematology;2024-02

3. Biological characteristics and clinical management of uveal and conjunctival melanoma;Oncology Research;2024

4. Therapie des Uveamelanoms*;InFo Hämatologie + Onkologie;2023-10

5. Uveamelanome;Die Onkologie;2023-07-13